Liu F,Lu Q,Ye X,et al.Cancer gene therapy of adenovirus-mediated anti-4-1BB scFv in immunocompetent mice[J].Cancer Biol Ther,2008,7(3):448-453.Liu F, Lu Q, Ye X, et al. Cancer gene therapy of adenovirus-mediated anti-4-1BB scFv in immunocompetent mice [J]. Cancer Biol Ther...
Anti-4-1BB scFv immunogene therapy and low dose cyclophosphamide exhibit a synergistic antitumor effect in established murine lung tumors. Cancer Biol Ther, 8(8), 707-713. :LIU FANG ET AL: "Anti-4-1BB scFv immunogene therapy and low dose cyclophosphamide exhibit a synergistic antitumor ...
Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector),78601-50 μl Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector) BPS bioscience总部坐落于世界最大之一的美国圣地亚哥生命科学研究机构和公司集中地的中心。公司主
Crystals of 4-1BB: ATOR-1017scFv complex at 12.5 mg/ml in 10 mM HEPES pH7.5, 150 mM NaCl generated after seeding, as depicted in Supplementary Figure S2, as a multi-needle crystal bunch. A single needle was removed from the bunch and used for data collection at 100 K at the BioMAX...
Anti-CD19 CAR consists of anti-CD19 scFv linked to 3rd generation CAR (Chimeric Antigen Receptor) containing CD28, 4-1BB co-stimulatory domains, and CD3ζ signaling domain. 会员登录 × 请输入账号 请输入密码 = 请输验证码 立即登录新用户注册 ...
●Purchase●DescriptionAnti-CD19CAR/NFAT(Luciferase)ReporterJurkatCellLine(CD19SCFV-CD28-4-1BB-CD3ζ)isastablecelllineexpressingananti-CD19CARandanNFAT-dependentluciferasereporter 详细介绍 ● Purchase ● Description Anti-CD19 CAR/NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-...
We generated two humanized anti-MSLN×4-1BB bsAbs (HK013-G1/G4) by fusing an anti-4-1BB scFv to the C-terminus of an anti-MSLN VHH with an intact Fc fragment from human IgG1 or IgG4. The two bsAbs were able to block the binding of CA125 to MSLN and stimulate 4-1BB signal...
We finally constructed EU505 that composed of a scFv of anti-4-1BB and euPD-1. Through cell binding and dual antigen assays, we confirmed that EU505 binds both targets independently at the same time. The result of 4-1BB bioassays, a biologically relevant MOA-based assay, showed that ...
Results: We generated two humanized anti-MSLN脳4-1BB bsAbs (HK013-G1/G4) by fusing an anti-4-1BB scFv to the C-terminus of an anti-MSLN VHH with an intact Fc fragment from human IgG1 or IgG4. The two bsAbs were able to block the binding of CA125 to MSLN and stimulate 4-...
5.The anti-4-1BB/anti-EGFR bispecific antibody of claim 4, wherein the anti-4-1BB scFv comprises:a heavy chain variable region comprising an H-CDR1 comprising an amino acid sequence of SEQ ID NO: 1, 2, or 3, an H-CDR2 comprising an amino acid sequence of SEQ ID NO: 4, 5, ...